ID

32391

Beschreibung

Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00457574

Link

https://clinicaltrials.gov/show/NCT00457574

Stichworte

Versionen (1)
  1. 29.10.18 29.10.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

29. Oktober 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Solid Tumors and Lymphomas NCT00457574

Englisch

Eligibility Solid Tumors and Lymphomas NCT00457574

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have a histologically or cytologically confirmed solid tumor or lymphoma
Beschreibung

Solid Neoplasm | Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0280100
UMLS CUI [2]
C0024299
no limitations on allowable type and amount of prior therapy.
Beschreibung

Limitation Absent Prior Therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0449295
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C1514463
patients must have a life expectancy of greater than 8 weeks
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
patients must have normal organ and marrow function
Beschreibung

Organ function | Bone Marrow function

Datentyp

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
patients must be willing to submit blood sampling for planned pk analysis
Beschreibung

Blood sampling Pharmacokinetic aspects

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005834
UMLS CUI [1,2]
C0031328
patients must have the ability to understand and willingness to sign a written informed consent form
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
no other agents or therapies administered with the intent to treat malignancy
Beschreibung

Pharmaceutical Preparations Other Cancer treatment | Cancer treatment Other

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0920425
UMLS CUI [2,1]
C0920425
UMLS CUI [2,2]
C0205394
patients with prior exposure to gmx1777 or gmx1778
Beschreibung

Exposure to GMX1777 | Exposure to GMX 1778

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C2346839
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C2713488
uncontrolled, intercurrent illness
Beschreibung

Comorbidity Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
pregnant women and women who are breast feeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Solid Tumors and Lymphomas NCT00457574

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Solid Neoplasm | Lymphoma
Item
patients must have a histologically or cytologically confirmed solid tumor or lymphoma
boolean
C0280100 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
Limitation Absent Prior Therapy
Item
no limitations on allowable type and amount of prior therapy.
boolean
C0449295 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
Life Expectancy
Item
patients must have a life expectancy of greater than 8 weeks
boolean
C0023671 (UMLS CUI [1])
Organ function | Bone Marrow function
Item
patients must have normal organ and marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Blood sampling Pharmacokinetic aspects
Item
patients must be willing to submit blood sampling for planned pk analysis
boolean
C0005834 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
Informed Consent
Item
patients must have the ability to understand and willingness to sign a written informed consent form
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Other Cancer treatment | Cancer treatment Other
Item
no other agents or therapies administered with the intent to treat malignancy
boolean
C0013227 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,3])
C0920425 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Exposure to GMX1777 | Exposure to GMX 1778
Item
patients with prior exposure to gmx1777 or gmx1778
boolean
C0332157 (UMLS CUI [1,1])
C2346839 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C2713488 (UMLS CUI [2,2])
Comorbidity Uncontrolled
Item
uncontrolled, intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant women and women who are breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video